|
|
Volumn 87, Issue 10, 2016, Pages 978-987
|
|
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GADOLINIUM;
INTERFERON BETA SERINE;
PLACEBO;
IMMUNOLOGICAL ADJUVANT;
ADULT;
ARTICLE;
BRAIN SIZE;
CLINICALLY DEFINITE MULTIPLE SCLEROSIS;
COMPARATIVE STUDY;
CONTRAST ENHANCEMENT;
CONTROLLED STUDY;
CROSS-SECTIONAL STUDY;
DEMYELINATING DISEASE;
DOUBLE BLIND PROCEDURE;
EARLY INTERVENTION;
EMPLOYMENT;
EXPANDED DISABILITY STATUS SCALE;
FEMALE;
FOLLOW UP;
HEALTH CARE UTILIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
MULTIPLE SCLEROSIS;
NEUROIMAGING;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PACED AUDITORY SERIAL ADDITION TEST;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RECURRENCE RISK;
RELAPSE;
THERAPY DELAY;
TIME TO TREATMENT;
UNSPECIFIED SIDE EFFECT;
CLINICAL TRIAL;
DIAGNOSTIC IMAGING;
DISABILITY;
KAPLAN MEIER METHOD;
RECURRENT DISEASE;
TREATMENT OUTCOME;
YOUNG ADULT;
ADJUVANTS, IMMUNOLOGIC;
ADULT;
CROSS-SECTIONAL STUDIES;
DEMYELINATING DISEASES;
DISABILITY EVALUATION;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INTERFERON BETA-1B;
KAPLAN-MEIER ESTIMATE;
MALE;
RECURRENCE;
TIME-TO-TREATMENT;
TREATMENT OUTCOME;
YOUNG ADULT;
|
|
EID: 84986238294
PISSN: 00283878
EISSN: 1526632X
Source Type: Journal
DOI: 10.1212/WNL.0000000000003078 Document Type: Article |
|
Times cited : (106)
|
|
References (2)
|
